Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549].

Bioorg Med Chem Lett

Medicinal Chemistry, Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address:

Published: September 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.bmcl.2022.128856	DOI Listing

Publication Analysis

corrigendum "optimization

"optimization novel

novel piperazinone

piperazinone series

series potent

potent selective

selective peripheral

peripheral covalent

covalent btk

btk inhibitors"

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!